Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Magic Formula for These Biotech Stocks
Motley Fool
Wednesday, January 26, 2011 - 8:55pm
tags:
biotech, Amgen, Biogen Idec, Gilead Sciences, Celgene
One Company That Benefits The Most From The Soaring Diabetes Epidemic
Forbes
Wednesday, January 26, 2011 - 8:53pm
tags:
Novo Nordisk, diabetes
FDA sees possible cancer risk with breast implants
Yahoo/AP
Wednesday, January 26, 2011 - 8:50pm
tags:
breast implants, FDA, cancer, anaplastic large-cell lymphoma, Allergan, JNJ
Timing Positive For Bydureon
Forbes
Wednesday, January 26, 2011 - 8:38pm
tags:
Bydureon, FDA, Amylin, QT intervals
Earnings Preview: Bristol-Myers
Yahoo/Zacks.com
Wednesday, January 26, 2011 - 12:48pm
tags:
earnings, Bristol-Myers Squibb
Clinical Data hires reps for Viibryd launch
Fierce Pharma
Wednesday, January 26, 2011 - 12:32pm
tags:
Viibryd, drug reps, Clinical Data, antidepressants
Amgen Makes Bet on Viral Skin Cancer Killer
TheStreet.com
Wednesday, January 26, 2011 - 12:22pm
tags:
skin cancer, Amgen, BioVex, M&A
Gilead Sciences: Sellers Are Missing the Bigger Picture
Seeking Alpha
Wednesday, January 26, 2011 - 12:21pm
tags:
Gilead Sciences
Misunderstood News Offers Opportunity for Deep Discount on Momenta Pharmaceuticals
Seeking Alpha
Wednesday, January 26, 2011 - 12:20pm
tags:
Momenta
Senators Reintroduce Pay-To-Delay Legislation
Pharmalot
Wednesday, January 26, 2011 - 12:18pm
tags:
Senate, pay-for-delay, FTC
Abbott’s Cutting More Jobs; Will Other Drug Makers Follow in 2011?
WSJ Online
Wednesday, January 26, 2011 - 12:16pm
tags:
Abbott Laboratories, layoffs
Report: Drug maker Elan cuts 130 jobs, mainly in South San Francisco, as execs take private jet
Bizjournals.com
Wednesday, January 26, 2011 - 12:15pm
tags:
layoffs, Elan
Abbott beats forecasts as drug sales shine
Yahoo/Reuters
Wednesday, January 26, 2011 - 10:49am
tags:
earnings, Abbott Laboratories, JNJ, Solvay
Decent Quarter for Dr. Reddy's
Yahoo/Zacks.com
Wednesday, January 26, 2011 - 10:47am
tags:
Dr Reddy's, earnings, AstraZeneca
Abbott Cuts 1,900 Jobs in Restructuring of Drug Unit
Bloomberg
Wednesday, January 26, 2011 - 10:46am
tags:
layoffs, Abbott Laboratories
Sanofi CEO Says Genzyme Progress Made, Still Some Differences
Bloomberg
Wednesday, January 26, 2011 - 8:06am
tags:
Sanofi, Genzyme, M&A, Pharma CEOs, Chris Viehbacher
Johnson & Johnson: Pullback Presents Buy Opportunity
Seeking Alpha
Wednesday, January 26, 2011 - 8:04am
tags:
JNJ
Will Depomed Get Past the FDA?
Motley Fool
Wednesday, January 26, 2011 - 8:03am
tags:
FDA, Depomed, DM-1796, shingles
FDA Approves Allegra Sale Without Prescription
WSJ Online
Tuesday, January 25, 2011 - 6:04pm
tags:
FDA, Allegra, allergies, Sanofi
Gilead's HIV Drug: FDA Returns to Sender
TheStreet.com
Tuesday, January 25, 2011 - 6:03pm
tags:
HIV, FDA, Gilead Sciences, B-tripla

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.